Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease (Q37259929)
Jump to navigation
Jump to search
scientific article published on 09 May 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease |
scientific article published on 09 May 2009 |
Statements
1 reference
Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease (English)
1 reference
Agneta Siegbahn
1 reference
Lars Wallentin
1 reference
Stefan James
1 reference
John T Brandt
1 reference
Christoph Varenhorst
1 reference
David Erlinge
1 reference
Oscar O Braun
1 reference
Michael Man
1 reference
Joseph Walker
1 reference
Kenneth J Winters
1 reference
Sandra L Close
1 reference
9 May 2009
1 reference
1 reference
1744-1752
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference